Transplantation

UNOS TMF 2019

Thanks to everyone who visited the EDITLife booth at UNOS TMF 2019! It was exciting to connect with so many industry leaders. The positive response to EDITLife Solid Organ Transplant- the patient-centric, transplant management software system that efficiently tracks and monitors solid organ transplant-specific data and supplements your EHR - inspired us to work even harder to ensure that EDITLife provides the tools and functionality transplant...

Read More

Thanks to everyone who stopped by the EDITLife booth at the TCT 2019 Meetings in Houston! We were thrilled to connect with so many industry leaders and with the positive response to EDITLife for Cell Therapy - the patient-centric, transplant management software system that efficiently tracks and monitors BMT-specific data and supplements your EHR. And, we were inspired to work even harder to ensure that...

Read More

Findings presented at the American Society of Nephrology's Kidney Week 2018 suggest that gout, a risk factor for serious poor health outcomes, is much more common among solid organ transplant recipients than in the general U.S. population. Using 2016 claims data, researchers found that the prevalence of active gout was 11.3% among solid organ transplant recipients - particularly kidney and heart transplant recipients -  compared...

Read More

MSA Life Sciences, developers of the EDITLife Transplant Management System (TMS), is pleased to be sponsoring the NMDP (National Marrow Donor Program) Council Meeting 2018 for the 3rd consecutive year. Division reps will demonstrate the state-of-the-art, EDITLife clinical workflow application at the event, which takes place November 9-10, at the Hilton in Minneapolis, MN.   Bringing together the professionals who work every day to ensure the best...

Read More

Penn Medicine launched an innovative clinical trial in 2016 to test the effect of transplanting kidneys from donors with Hepatitis C virus (HCV) into patients currently on the kidney waitlist who do not have the virus and would opt in to receive these otherwise unused organs. After transplantation, recipients were treated with an antiviral therapy in an effort to cure the virus. To date, 20 patients have...

Read More

Nearly 2,000 children under 18 years old are on the U.S. organ transplant waiting list. Of those, approximately 500 are children ages 1 to 5. In order to raise awareness of the need for organ donors, several transplant organizations - including Transplant Families - is introducing the first annual National Pediatric Transplant Week, April 23-27. As part of National Donate Life Month, this week gives...

Read More

A novel imaging test using the imaging agent 18F-fluorothymidine (18FLT) identifies success of HSCT engraftment weeks before a traditional blood test. This imaging technique — a less painful option than bone marrow biopsies — also allowed researchers to better understand the engraftment process following HSCT. A study led by blood and marrow transplant specialists at Children's National Health System suggest that 18FLT could be useful to assess subclinical...

Read More

University of California, San Francisco, pediatric surgeons treated a fetus diagnosed with a lethal form of thalassemia, alpha thalassemia major, with stem cells from her mother's bone marrow. Born in February, the baby was the first patient enrolled in the world's first clinical trial using stems cell prior to birth. Every fetus has the perfect donor: mom. Although it is too early to say how effective the...

Read More